OBJECTIVE: To test the hypothesis that variability in SNCA Rep1, a polymorphic dinucleotide microsatellite in the promoter region of the gene encoding α-synuclein, modifies the association between head injury and Parkinson's disease (PD) risk. METHODS:Participants in the Farming and Movement Evaluation (FAME) and the Study of Environmental Association and Risk of Parkinsonism using Case-Control Historical Interviews (SEARCH), 2 independent case-control studies, were genotyped for Rep1 and interviewed regarding head injuries with loss of consciousness or concussion prior to Parkinson's disease (PD) diagnosis. Logistic regression modeling adjusted for potential confounding variables and tested interaction between Rep1 genotype and head injury. RESULTS: Consistent with prior reports, relative to medium-length Rep1, short Rep1 genotype was associated with reduced PD risk (pooled odds ratio [OR], 0.7; 95% confidence interval [CI], 0.5-0.9), and long Rep1 with increased risk (pooled OR, 1.4; 95% CI, 0.95-2.2). Overall, head injury was not significantly associated with PD (pooled OR, 1.3; 95% CI, 0.9-1.8). However, head injury was strongly associated with PD in those with long Rep1 (FAME OR, 5.4; 95% CI, 1.5-19; SEARCH OR, 2.3; 95% CI, 0.6-9.2; pooled OR, 3.5; 95% CI 1.4-9.2, p-interaction = 0.02). Individuals with both head injury and long Rep1 were diagnosed 4.9 years earlier than those with neither risk factor (p = 0.03). INTERPRETATION: While head injury alone was not associated with PD risk, our data suggest head injury may initiate and/or accelerate neurodegeneration when levels of synuclein are high, as in those with Rep1 expansion. Given the high population frequency of head injury, independent verification of these results is essential.
RCT Entities:
OBJECTIVE: To test the hypothesis that variability in SNCARep1, a polymorphic dinucleotide microsatellite in the promoter region of the gene encoding α-synuclein, modifies the association between head injury and Parkinson's disease (PD) risk. METHODS:Participants in the Farming and Movement Evaluation (FAME) and the Study of Environmental Association and Risk of Parkinsonism using Case-Control Historical Interviews (SEARCH), 2 independent case-control studies, were genotyped for Rep1 and interviewed regarding head injuries with loss of consciousness or concussion prior to Parkinson's disease (PD) diagnosis. Logistic regression modeling adjusted for potential confounding variables and tested interaction between Rep1 genotype and head injury. RESULTS: Consistent with prior reports, relative to medium-length Rep1, short Rep1 genotype was associated with reduced PD risk (pooled odds ratio [OR], 0.7; 95% confidence interval [CI], 0.5-0.9), and long Rep1 with increased risk (pooled OR, 1.4; 95% CI, 0.95-2.2). Overall, head injury was not significantly associated with PD (pooled OR, 1.3; 95% CI, 0.9-1.8). However, head injury was strongly associated with PD in those with long Rep1 (FAME OR, 5.4; 95% CI, 1.5-19; SEARCH OR, 2.3; 95% CI, 0.6-9.2; pooled OR, 3.5; 95% CI 1.4-9.2, p-interaction = 0.02). Individuals with both head injury and long Rep1 were diagnosed 4.9 years earlier than those with neither risk factor (p = 0.03). INTERPRETATION: While head injury alone was not associated with PD risk, our data suggest head injury may initiate and/or accelerate neurodegeneration when levels of synuclein are high, as in those with Rep1 expansion. Given the high population frequency of head injury, independent verification of these results is essential.
Authors: Kenneth D Cronin; Dongliang Ge; Paul Manninger; Colton Linnertz; Anna Rossoshek; Bonnie M Orrison; David J Bernard; Omar M A El-Agnaf; Michael G Schlossmacher; Robert L Nussbaum; Ornit Chiba-Falek Journal: Hum Mol Genet Date: 2009-06-04 Impact factor: 6.150
Authors: Caroline M Tanner; G Webster Ross; Sarah A Jewell; Robert A Hauser; Joseph Jankovic; Stewart A Factor; Susan Bressman; Amanda Deligtisch; Connie Marras; Kelly E Lyons; Grace S Bhudhikanok; Diana F Roucoux; Cheryl Meng; Robert D Abbott; J William Langston Journal: Arch Neurol Date: 2009-09
Authors: H Wilms; P Rosenstiel; M Romero-Ramos; A Arlt; H Schäfer; D Seegert; P J Kahle; S Odoy; J H Claasen; C Holzknecht; L O Brandenburg; G Deuschl; S Schreiber; D Kirik; R Lucius Journal: Int J Immunopathol Pharmacol Date: 2009 Oct-Dec Impact factor: 3.219
Authors: Colton Linnertz; Laura Saucier; Dongliang Ge; Kenneth D Cronin; James R Burke; Jeffrey N Browndyke; Christine M Hulette; Kathleen A Welsh-Bohmer; Ornit Chiba-Falek Journal: PLoS One Date: 2009-10-16 Impact factor: 3.240
Authors: Kathryn M Taylor; Marie-Helene Saint-Hilaire; Lewis Sudarsky; David K Simon; Bonnie Hersh; David Sparrow; Howard Hu; Marc G Weisskopf Journal: Parkinsonism Relat Disord Date: 2015-12-19 Impact factor: 4.891
Authors: Raquel C Gardner; James F Burke; Jasmine Nettiksimmons; Sam Goldman; Caroline M Tanner; Kristine Yaffe Journal: Ann Neurol Date: 2015-03-28 Impact factor: 10.422
Authors: Aaron J Carman; Rennie Ferguson; Robert Cantu; R Dawn Comstock; Penny A Dacks; Steven T DeKosky; Sam Gandy; James Gilbert; Chad Gilliland; Gerard Gioia; Christopher Giza; Michael Greicius; Brian Hainline; Ronald L Hayes; James Hendrix; Barry Jordan; James Kovach; Rachel F Lane; Rebekah Mannix; Thomas Murray; Tad Seifert; Diana W Shineman; Eric Warren; Elisabeth Wilde; Huntington Willard; Howard M Fillit Journal: Nat Rev Neurol Date: 2015-03-17 Impact factor: 42.937
Authors: Line Kenborg; Kathrine Rugbjerg; Pei-Chen Lee; Line Ravnskjær; Jane Christensen; Beate Ritz; Christina F Lassen Journal: Neurology Date: 2015-02-13 Impact factor: 9.910